Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.69 Million ≈ $8.15 Million USD) by net assets (CN¥1.33 Billion ≈ $194.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Cheng Yi Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Zhejiang Cheng Yi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Cheng Yi Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Wild Bunch AG F:WBAH	-0.008x
MN Holdings Berhad KLSE:0245	0.245x
Gallant Precision Machining Co Ltd TWO:5443	0.031x
KKR Credit Income Fund AU:KKC	0.040x
Pangaea Logistic NASDAQ:PANL	0.061x
Jiangsu Rijiu Optoelectronics Joint SHE:003015	0.042x
ACNB Corporation NASDAQ:ACNB	0.030x
VIP Industries Limited NSE:VIPIND	0.136x

Annual Cash Flow Conversion Efficiency for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.40 Billion ≈ $204.54 Million	CN¥280.39 Million ≈ $41.03 Million	0.201x	+23.36%
2024-12-31	CN¥1.27 Billion ≈ $185.12 Million	CN¥205.72 Million ≈ $30.10 Million	0.163x	-0.10%
2023-12-31	CN¥1.20 Billion ≈ $175.10 Million	CN¥194.78 Million ≈ $28.50 Million	0.163x	+7.02%
2022-12-31	CN¥1.09 Billion ≈ $159.64 Million	CN¥165.94 Million ≈ $24.28 Million	0.152x	+5.89%
2021-12-31	CN¥998.88 Million ≈ $146.17 Million	CN¥143.49 Million ≈ $21.00 Million	0.144x	-28.41%
2020-12-31	CN¥886.09 Million ≈ $129.66 Million	CN¥177.81 Million ≈ $26.02 Million	0.201x	-14.76%
2019-12-31	CN¥768.96 Million ≈ $112.52 Million	CN¥181.01 Million ≈ $26.49 Million	0.235x	+18.06%
2018-12-31	CN¥673.54 Million ≈ $98.56 Million	CN¥134.30 Million ≈ $19.65 Million	0.199x	+79.10%
2017-12-31	CN¥599.57 Million ≈ $87.74 Million	CN¥66.75 Million ≈ $9.77 Million	0.111x	-67.19%
2016-12-31	CN¥280.17 Million ≈ $41.00 Million	CN¥95.08 Million ≈ $13.91 Million	0.339x	+7.65%
2015-12-31	CN¥259.92 Million ≈ $38.03 Million	CN¥81.94 Million ≈ $11.99 Million	0.315x	-7.44%
2014-12-31	CN¥246.95 Million ≈ $36.14 Million	CN¥84.11 Million ≈ $12.31 Million	0.341x	+42.35%
2013-12-31	CN¥201.40 Million ≈ $29.47 Million	CN¥48.19 Million ≈ $7.05 Million	0.239x	+12.28%
2012-12-31	CN¥178.13 Million ≈ $26.07 Million	CN¥37.96 Million ≈ $5.55 Million	0.213x	+117.73%
2011-12-31	CN¥102.60 Million ≈ $15.01 Million	CN¥10.04 Million ≈ $1.47 Million	0.098x	--

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

SHG:603811 China Drug Manufacturers - Specialty & Generic

Market Cap

$483.45 Million

CN¥3.30 Billion CNY

Market Cap Rank

#12374 Global

#3597 in China

Share Price

CN¥7.21

Change (1 day)

-0.14%

52-Week Range

CN¥6.93 - CN¥16.82

All Time High

CN¥19.93